Bgm (BGM) Assets Average (2020 - 2025)
Bgm's (BGM) quarterly Assets Average came in at $320.6 million in Q3 2025, up 1134.05% year-on-year from $26.0 million in Q3 2024, and up 206.06% on a QoQ basis from $104.8 million in Q1 2025.
Bgm (BGM) Assets Average (2020 - 2025) Analysis & Trends
Bgm (BGM) has 6 years of Assets Average data on file, last reported at $320.6 million in Q3 2025.
- On a quarterly basis, Assets Average rose 1134.05% year-over-year to $320.6 million in Q3 2025; TTM through Sep 2025 was $320.6 million, a 1134.05% increase from a year earlier, with the FY2025 full-year figure at $218.0 million, up 716.86% from the prior year.
- Assets Average for Q3 2025 stood at $320.6 million, up from $104.8 million in the prior quarter.
- Over the last five years, Assets Average for BGM reached as high as $320.6 million in Q3 2025 and fell as low as $24.1 million in Q1 2021.
- Historically, Assets Average has averaged $69.1 million across 5 years, with a median of $35.0 million in 2021.
- Across the five-year window, Assets Average dropped 20.56% in 2023 and jumped 1134.05% in 2025, its largest moves.
- Year by year, Assets Average stood at $37.7 million in 2021, then retreated by 14.37% to $32.3 million in 2022, then decreased by 20.56% to $25.6 million in 2023, then increased by 1.37% to $26.0 million in 2024, then soared by 1134.05% to $320.6 million in 2025.
- Per Business Quant data, the three most recent Assets Average figures were $320.6 million in Q3 2025, $104.8 million in Q1 2025, and $26.0 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 7.30 Bn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | 21.86 Mn |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Bgm | 33.55 Mn | 23.73 Mn | - | 320.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 320.60 Mn |
| Mar 31, 2025 | 104.75 Mn |
| Sep 30, 2024 | 25.98 Mn |
| Mar 31, 2024 | 50.56 Mn |
| Sep 30, 2023 | 25.63 Mn |
| Mar 31, 2023 | 32.26 Mn |
| Sep 30, 2022 | 32.26 Mn |
| Mar 31, 2022 | 37.68 Mn |
| Sep 30, 2021 | 37.68 Mn |
| Mar 31, 2021 | 24.07 Mn |
| Sep 30, 2020 | 41.71 Mn |